Thierry MESANA, MD, PhD President and CEO Professor Cardiac Surgery

Slides:



Advertisements
Similar presentations
Mitral valve. Repair vs. Replacement >%80 of MR are repairable Produces more physiological flow states It better preserves LV function Less thrombolic.
Advertisements

Percutaneous mitral valve repair using the MitraClip® device (e-valve)
Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation Right Ventricular Function and Pulmonary Artery Hypertension After Degenerative.
©2015 MFMER | Robotic Repair of Simple vs. Complex Degenerative Mitral Valve Disease Clinical and Echocardiographic Outcomes During Mid-Term.
EVEREST II Study Design Multicenter Randomized in a 2:1 ratio to either percutaneous or conventional surgery for the repair or replacement of the mitral.
+ Mitral Valve Prolapse A Surgeon’s Perspective Charles Anderson, M.D. Saint Joseph’s Hospital of Atlanta.
Asymptomatic mitral regurgitation When should you operate? Ben Bridgewater Cardiac surgeon and lead clinician, UHSM, Manchester Honorary Reader, Manchester.
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
Current Surgical Standards for Mitral Leaflet and Chordal Repair: Patient Selection,Techniques and Clinical Outcomes CRT February 2011 Niv Ad, MD Chief,
Role of Device Therapy in FMR: Challenges and Opportunities
Minimally Invasive Mitral Valve Repair
The Rheumatic Mitral Valve and Repair Techniques in Children
Mitral Regurgitation: Epidemiology, Pathophysiology and When to Repair
Division of Cardiac Surgery University of Ottawa Heart Institute
The Spectrum of Evolving Mitral Repair Techniques
How I treat Functional Mitral Regurgitation: The Surgeon’s perspective
Surgical Mitral Valve Repair: What is the Gold Standard?
Annual Outcomes With Transcatheter Valve Therapy
James Hermiller, MD, FACC, FSCAI St Vincent Hospital, Indianapolis, IN
Figure 1: IPW-adjusted cumulative incidence function of cardiac death at 12 years, with non-cardiac death as competing risk. IPW: inverse probability of.
Long-term durability of Edwards bioprosthetic aortic valves
Annual Outcomes With Transcatheter Valve Therapy
Longitudinal Outcome of Isolated Mitral Repair in Older Patients: Results From 14,604 Procedures Performed From 1991 to 2007  Vinay Badhwar, MD, Eric.
Late Follow-Up from the PARTNER Aortic Valve-in-Valve Registry
Cardiovacular Research Technologies
Nishith Patel Waikato Cardiothoracic Unit
Extending the Scope of Mitral Valve Repair in Rheumatic Disease
Feasibility and Intermediate Term Outcome of Repair of Prolapsing Anterior Mitral Leaflets With Artificial Chordal Replacement in 152 Patients  Gerald.
Sorin Bicarbon: 17 years of clinical use
Surgical approach to repair of ruptured chordae tendineae causing tricuspid regurgitation  Vincent Chan, MD, Dominique Grisoli, MD, Marc Ruel, MD, MPH,
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,
Very long-term durability of the edge-to-edge repair for isolated anterior mitral leaflet prolapse: Up to 21 years of clinical and echocardiographic results 
Improved Mitral Valve Performance After Transapical Aortic Valve Implantation  Martin Haensig, MD, David Michael Holzhey, MD, PhD, Michael Andrew Borger,
Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation  Matthew L. Williams, MD,
Clinical Impact of Mild Acute Kidney Injury After Cardiac Surgery
Antonio M. Calafiore, MD  The Annals of Thoracic Surgery 
Reoperation After Mitral Valve Repair for Degenerative Disease
Barlow's Mitral Valve Disease: A Comparison of Neochordal (Loop) and Edge-To-Edge (Alfieri) Minimally Invasive Repair Techniques  Jaqueline G. da Rocha.
Early and follow-up results of butterfly resection of prolapsed posterior leaflet in 76 consecutive patients  Tohru Asai, MD, PhD, Takeshi Kinoshita,
Surgical Repair of Posterior Mitral Valve Prolapse: Implications for Guidelines and Percutaneous Repair  Douglas R. Johnston, MD, A. Marc Gillinov, MD,
Benefits of Early Surgery on Clinical Outcomes After Degenerative Mitral Valve Repair  Tianyu Zhou, MD, Jun Li, MD, PhD, Hao Lai, MD, PhD, Kai Zhu, MD,
Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery  Vincent Chan, MD, MPH, Thierry.
Clinical and echocardiographic outcomes after repair of mitral valve bileaflet prolapse due to myxomatous disease  Vincent Chan, MD, MPH, Marc Ruel, MD,
Chordae Replacement Versus Resection for Repair of Isolated Posterior Mitral Leaflet Prolapse: À Ègalité  Joerg Seeburger, MD, Volkmar Falk, MD, PhD,
A “Repair-All” Strategy for Degenerative Mitral Valve Disease Safely Minimizes Unnecessary Replacement  Andrew B. Goldstone, MD, Jeffrey E. Cohen, MD,
Mitral valve operation in patients with the Marfan syndrome
The Rheumatic Mitral Valve and Repair Techniques in Children
Volume 15, Issue 1, Pages (January 2012)
Impact of Failed Mitral Clipping on Subsequent Mitral Valve Operations
Survival Prediction in Patients Undergoing Open-Heart Mitral Valve Operation After Previous Failed MitraClip Procedures  Stephan Geidel, MD, Peter Wohlmuth,
Eight-Year Outcomes of Tricuspid Annuloplasty Using Autologous Pericardial Strip for Functional Tricuspid Regurgitation  Byung-Chul Chang, MD, PhD, Suk-Won.
Alexander Kulik, MD, Manal Al-Saigh, MD, Vincent Chan, MD, Roy G
Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement  Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,
Minimally Invasive Fibrillating Heart Surgery: A Safe and Effective Approach for Mitral Valve and Surgical Ablation for Atrial Fibrillation  Paul S. Massimiano,
A near 100% repair rate for mitral valve prolapse is achievable in a reference center: Implications for future guidelines  Javier G. Castillo, MD, Anelechi.
Intermediate-term results of a nonresectional dynamic repair technique in 662 patients with mitral valve prolapse and mitral regurgitation  Gerald M.
Xujun Chen, MD, PhD, Ryan S. Turley, MD, Nicholas D
Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation  Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.
Clinical evaluation of functional mitral stenosis after mitral valve repair for degenerative disease: Potential affect on surgical strategy  Thierry G.
One Hundred Percent Reparability of Degenerative Mitral Regurgitation: Intermediate- Term Results of a Dynamic Engineered Approach  Gerald M. Lawrie, MD,
John M. Stulak, MD, Rakesh M. Suri, MD, DPhil, Joseph A
Tirone E. David, MD, Carolyn M. David, BN, Cedric Manlhiot, MS 
Survival Advantage and Improved Durability of Mitral Repair for Leaflet Prolapse Subsets in the Current Era  Rakesh M. Suri, MD, DPhil, Hartzell V. Schaff,
Late incidence and determinants of stroke after aortic and mitral valve replacement  Marc Ruel, MD, MPH, Roy G Masters, MD, Fraser D Rubens, MD, Pierre.
Mitral Valve Surgery in Patients With Severe Mitral Annular Calcification  Tomoya Uchimuro, MD, Toshihiro Fukui, MD, Atsushi Shimizu, MD, Shuichirou Takanashi,
Roland Fasol, MD, Katja Mahdjoobian, MD  The Annals of Thoracic Surgery 
Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience  Tirone E. David, MD, Susan Armstrong, MSc, Joan.
Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve?  Kevin M Harris, MD, Thoralf M Sundt,
Evelio Rodriguez, MD, L. Wiley Nifong, MD, Michael W. A
Reoperative mitral valve replacement: importance of preservation of the subvalvular apparatus  Michael A Borger, MD, PhD, Terrence M Yau, MD, MS, Vivek.
Presentation transcript:

ACUTE AND LATE RESULTS AFTER SURGICAL REPAIR/REPLACEMENT OF DEGENERATIVE MITRAL REGURGITATION Thierry MESANA, MD, PhD President and CEO Professor Cardiac Surgery Valve Surgery Research Chair University of Ottawa Heart Institute Ottawa, Ontario, Canada

I have no relevant financial relationships

Important questions Immediate results : Operative Risk in mitral valve surgery and Variations in repair rates : Variations depending on Volumes and Expertise Long-term results : Durability of MV repair for MV Prolapse Recurrence of MR, Functional MS due to small rings

EARLY MORTALITY/OPERATIVE RISK Mitral Repair Mitral Replacement 0.9% (Castillo JTCVS 2012) 1.2% (Coutinho EJCTS 2016) Expert centers usually below 0.5 % 1.8% (Coutinho EJCTS 2016) 3.3% (Bourguignon JTCVS 2014) 7.2% (McClure Ann Thorac Surg 2010) CRT 2017

Mitral Valve Replacement Perioperative deaths after MV operations may be overestimated by contemporary risk models Presented at STS meeting January, 2014., Annals of TS July 2014 Mitral Valve Surgery N = 1154 Mitral Valve Repair N = 851 Mitral Valve Replacement N = 303 Follow up and also this is not clear Study Dates: 2001-2011

Observed & EuroSCORE II Predicted Mortality Isolated Mitral Surgery Ottawa Heart Institute series 2002-2013 (Annals TS, July 2014) EuroSCORE II Quartile N Observed Mortality Predicted Mortality Lower Limit (%) Upper Limit (%) 1 141 0 (0%) 0.5 0.7 2 143 1.0 3 142 2 (1.4%) 1.8 4 144 25.2 Patients were also grouped into quartiles according to their EuroSCORE II. Again, Overall O:E ratio 0.3

Observed & EuroSCORE II Predicted Mortality All procedures including Mitral valve Surgery Ottawa Heart Institute series 2001-2011 (Annals TS, July 2014) EuroSCORE II Quartile N Observed Mortality Predicted Mortality Lower Limit (%) Upper Limit (%) 1 285 1 (0.4%) 0.5 0.9 2 291 2 (0.7%) 1.7 3 288 3 (1.1%) 1.8 3.9 4 290 5 (1.7%) 31.1 Patients were also grouped into quartiles according to their EuroSCORE II. Again, Overall O:E ratio 0.3

Low Surgeon volume + low hospital volume : 5.6 % The effect of hospital volume on outcomes in MV surgery is also driven by individual surgeon within this hospital 30-day Mortality Low Surgeon volume + low hospital volume : 5.6 % Low surgeon volume + high Hospital Volume : 3.3% High surgeon volume + low Hospital volume : 2.3% High surgeon volume + high hospital volume : 2.0% Kilic et al . JTCVS 2013:146:638-46 (J Hopkins, Baltimore)

REPAIR RATE Depends on surgeon and on anatomy for a given surgeon Nationwide Isolated MV surgery 2003-2008, including 25,427 MV repairs (50.7%) Median volumes was 61 for hospitals and 12 for surgeons.( Kilic et al JTCVS 2013:146:638-46). Repair rates from 30 to 60% for all etiologies. Expert centers between 95 and 100% for MV Prolapse repair Only 3 surgeons >100 MV/year, majority less than 25/year Only 4 hospitals >200 MV /year, majority below 100/year A given surgeon may have an overall repair rate of 90%, a repair rate of 90-95% for fibroelastic deficiency with single segment posterior leaflet prolapse due to chordal rupture, but a lower success rate for bileaflet Barlow’s disease (<90%) Patients referred for MV repair should be considered on an individual basis, i-e for each case probability of repair by the surgeon > institution.

VARIATION IN SURGEON MITRAL REPAIR RATES J Thorac Cardiovasc Surg 2014;148:995-1004

LONG-TERM DURABILTY OF MITRAL VALVE REPAIR Excellent , not perfect

Chordal replacement with PTFE 25-year experience (T David Chordal replacement with PTFE 25-year experience (T David. JTCVS 2013;145:1563-9) 1986-2004 ; 606 consecutive pts AL 18%, PL 30%, BL 52%, 13 annular reconstructions (3%), 2 to 38 neochords per patient (mean 13), resection if PL height >20mm 90 % freedom from reoperation at 18 years 90% freedom from severe MR 67% freedom from mod/severe MR Anterior Leaflet Prolapse predictive for reoperation, as well as older age, HBP and low EF (<40%) Total of 35 reoperations. 32 replacement, 3 re-repairs (1 week to 22 y)

David T. E. et al.; J Thorac Cardiovasc Surg 2005;130:1242-1249 Freedom from recurrent moderate or severe mitral regurgitation (MR) in patients with posterior (PL), anterior (AL), and bileaflet (BL) prolapse David T. E. et al.; J Thorac Cardiovasc Surg 2005;130:1242-1249

Long-Term Durability Edge-to Edge for Anterior Leaflet Prolapse M Long-Term Durability Edge-to Edge for Anterior Leaflet Prolapse M.DeBonis (Alfieri’s Group)- JTCVS, 2014:Vol 148, 2027-32 1991-2004:139 pts, mean age 54 years, mean LVEF 56% Isolated AL prolapse/flail. A2 in 105 pts (75%), A1 or A3 (25%) E-to-E technique plus annuloplasty 11 years mean duration of follow-up 11 years, up to 21 years Moderate MR at discharge : 9pts (6,4%) 72% actuarial survival, 89% freedom from reoperation 82% freedom from severe MR (Grade 3 or 4) Predictors of severe MR : more than mild MR at discharge and pericardial ring annuloplasty instead of Prosthetic

Very Late outcomes after MV replacement with CE pericardial bioprosthesis Bourguignon et al, J Thorac Cardiovasc Surg 2014;148:2004-11 450 Isolated MV Replacement (404 pts). CE Perimount in 404 pts 1984-2011; Mean age 68; 53% female; Mean follow-up 7.2 years, up to 20 years Pts <65 y-o, freedom from SVD was 47% (15 years) and 19 % (20 years) and freedom from reoperation was 50% (15 years ) and 25% ( 20 years) Pts >65 y-o, freedom from SVD 62.5% at 15 y and 30% at 20 y , and freedom from reoperation 75% at 15 years

HOW DOES MITRAL VALVE REPAIR FAIL IN PATIENTS WITH PROLAPSE HOW DOES MITRAL VALVE REPAIR FAIL IN PATIENTS WITH PROLAPSE? – INSIGHTS FROM LONGITUDINAL ECHOCARDIOGRAPHIC FOLLOW-UP Vincent Chan, MD, MPH; Elsayed Elmistekawy, MD; Marc Ruel, MD, MPH; Marc Hynes, MD; Thierry G. Mesana, MD PhD PRESENTED at Society of Thoracic Surgeons Annual Meeting January 2016 Published: The Annals of Thoracic Surgery Volume 102, Issue 5, November 2016, Pages 1459–1465

Mitral Valve Repair of Myxomatous Degeneration N = 855 Study Dates: 2001-2015 Mitral Valve Repair of Myxomatous Degeneration N = 855 Patients assessed regularly in a dedicated clinic with serial echocardiographic assessments 1, 3-6 months, & 12-months Clinical & Echocardiographic assessments Annually thereafter Follow up and also this is not clear Clinical Follow-up 4.3 ± 3.5 years

MITRAL VALVE PATHOLOGY Moderate-Severe MAC 83/855 = .09707602 Prolapse ≥2 Anterior Leaflet Scallops 33(4%) Prolapse ≥2 Posterior Leaflet Scallops 100(12%) Mitral Annular Calcification 109 (13%)

REPAIR TECHNIQUES Annuloplasty Size 30.4 ± 5.8 mm Sliding plasty 263 (31%) Chordal Transfer 170 (20%) Artificial Neochordae 241 (28%) Edge-to-Edge 170 (20%) Conversion to replacement: 25 (2.8%) 30-day mortality : 0.4 % 35% combined procedures

Fig 1. Freedom from New York Heart Association (NYHA) III/IV symptoms, recurrent mitral regurgitation (MR) of 2+ or higher, and mitral valve reoperation, and survival are described for 855 patients with a follow-up of 4.3 ± 3.5 years. A total of 2,754 postoper... Vincent Chan, Elsayed Elmistekawy, Marc Ruel, Mark Hynes, Thierry G. Mesana How Does Mitral Valve Repair Fail in Patients With Prolapse?—Insights From Longitudinal Echocardiographic Follow-Up The Annals of Thoracic Surgery, Volume 102, Issue 5, 2016, 1459–1465 http://dx.doi.org/10.1016/j.athoracsur.2016.08.088

POSTOPERATIVE MR Proportion of Total (%) Mean Echocardiographic Follow-up 3.8 ± 3.2 years

FREEDOM FROM MV REOPERATION 100% 75% 96.9 ± 0.6% @ 5-years 50% 93.8 ± 1.2% @ 10-years 25% 0% 1 2 3 4 5 6 7 8 9 10 11 12 13 Patients at risk Reoperation 855 670 510 455 403 354 267 201 150 101 65

PREDICTORS FOR MITRAL REOPERATION Recurrent MR after 1-year Recurrent MR after 2-years Recurrent MR after 3-years afteroneyear | 5.201912 2.8908 2.97 0.003 1.750388 15.45937 After 2 years | 3.22807 2.399721 1.58 0.115 .7519113 13.8586 After 3 years | 1.893182 1.939934 0.62 0.533 .2540799 14.106345.45937 1 5 10 15 Incident Rate Ratio

ASSESSING FUNCTIONAL MITRAL STENOSIS AFTER “SUCCESSFUL”MITRAL VALVE REPAIR CRT 2017

RESULTS Functional MS after MV repair for Degenerative MR Impact of Annuloplasty type . Bands vs, full rings J Thorac Cardiovasc Surg 2013 Dec;146(6):1418-23 Mesana at al, University of Ottawa Heart Institute The higher gradients observed in patients with rings at rest, were also observed at peak exercise. In fact, the mean mitral gradient at peak stress was higher in the ring group as compared to the band group for all annuloplasty sizes. 3 reoperations for severe MS post full Ring ring less than 30 mm size

SUMMARY Severe MR after repair is rare, although some may have recurrent moderate MR (4-5%) Patients who require subsequent mitral valve reoperation were most likely to have recurrent MR ≥2+ within the first year after surgery suggesting that valve surveillance beyond a year may not be needed in asymptomatic patients Look for FUNCTIONAL MS in patients with FULL RINGS BELOW 30-32 mm In this series … Although there was …

THANK YOU

MI mitral valve surgery is associated with adverse events Nationwide STS Database LESS INVASIVE VERSUS CONVENTIONAL Stroke risk x2 (x3 if fibrillating heart) Gammie et al. Ann Thorac Surg 2010;90:1401-1410 EQUAL ONLY IN EXPERT/HIGH VOLUMES MIS CENTERS

Interval From Repair (years) RECURRENT MR ≥2+ Mode of Failure N (%) Interval From Repair (years) Prolapse Recurrent Other site 6 2 4 2.7 ± 2.1 3.9 ± 3.0 2.8 ± 2.8 No Prolapse Central jet Eccentric jet 43 14 24 3.2 ± 2.9 4.0 ± 3.6 3.1 ± 2.6 Group 1 | 3.920773 3.05445 1.760951 6.080595 Group 2 | 2.807381 2.789991 .1052361 5.677618 Group 3 | 3.95386 3.62323 .3607118 10.17 Group 4 | 3.082 2.551206 .0778576 8.300479